L2 Consulting works with an international client base of life science industries in finance, business planning, M+A, program design, executional oversight and interim management.  Scientifically, L2 has contributed to over 300 new drug clinical trial applications (preclinical), has raised over U$200m in new funding and has been pivotal in closing 6 mid-sized M&A’s in the industry (including execution of full due diligence) with deal values of up to US$50m.